SFM

Sphera Funds Management Portfolio holdings

AUM $382M
This Quarter Return
-1.04%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$541M
AUM Growth
+$541M
Cap. Flow
-$24.3M
Cap. Flow %
-4.49%
Top 10 Hldgs %
32.22%
Holding
125
New
17
Increased
28
Reduced
37
Closed
22

Top Buys

1
GOOG icon
Alphabet (Google) Class C
GOOG
$8.28M
2
ANNX icon
Annexon
ANNX
$6.38M
3
ORA icon
Ormat Technologies
ORA
$5.35M
4
ELDN icon
Eledon Pharmaceuticals
ELDN
$5.17M
5
SEDG icon
SolarEdge
SEDG
$5.1M

Top Sells

1
AAPL icon
Apple
AAPL
$14.2M
2
TEVA icon
Teva Pharmaceuticals
TEVA
$12.4M
3
AMZN icon
Amazon
AMZN
$9.43M
4
S icon
SentinelOne
S
$6.62M
5
NICE icon
Nice
NICE
$6.09M

Sector Composition

1 Healthcare 74.91%
2 Technology 16.21%
3 Communication Services 3.96%
4 Consumer Discretionary 2.54%
5 Utilities 0.99%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
APLS icon
26
Apellis Pharmaceuticals
APLS
$3.51B
$6.58M 1.19%
206,251
-9,622
-4% -$307K
IMTX icon
27
Immatics
IMTX
$662M
$6.55M 1.18%
921,111
+200,000
+28% +$1.42M
ANNX icon
28
Annexon
ANNX
$225M
$6.38M 1.15%
+1,243,039
New +$6.38M
ABBV icon
29
AbbVie
ABBV
$374B
$6.09M 1.1%
34,256
-3,744
-10% -$665K
MRK icon
30
Merck
MRK
$210B
$5.93M 1.07%
59,600
– –
BHVN icon
31
Biohaven
BHVN
$1.71B
$5.85M 1.06%
156,494
+23,171
+17% +$865K
RZLT icon
32
Rezolute
RZLT
$630M
$5.71M 1.03%
1,165,895
-31,043
-3% -$152K
FROG icon
33
JFrog
FROG
$5.58B
$5.6M 1.01%
190,381
+70,000
+58% +$2.06M
DYN icon
34
Dyne Therapeutics
DYN
$1.92B
$5.57M 1.01%
236,262
+179,758
+318% +$4.24M
MRUS icon
35
Merus
MRUS
$5.04B
$5.49M 0.99%
130,532
-17,101
-12% -$719K
NTLA icon
36
Intellia Therapeutics
NTLA
$1.26B
$5.43M 0.98%
466,080
+175,000
+60% +$2.04M
ORA icon
37
Ormat Technologies
ORA
$5.51B
$5.35M 0.97%
+79,000
New +$5.35M
KURA icon
38
Kura Oncology
KURA
$732M
$5.31M 0.96%
610,087
– –
ACAD icon
39
Acadia Pharmaceuticals
ACAD
$4.34B
$5.29M 0.96%
288,539
+36,000
+14% +$661K
SEDG icon
40
SolarEdge
SEDG
$1.97B
$5.1M 0.92%
+375,000
New +$5.1M
NVS icon
41
Novartis
NVS
$248B
$4.87M 0.88%
50,000
– –
CYBN
42
Cybin
CYBN
$142M
$4.75M 0.86%
538,111
-395,114
-42% -$3.48M
SKYE icon
43
Skye Bioscience
SKYE
$104M
$4.43M 0.8%
1,564,628
+1,106
+0.1% +$3.13K
GSK icon
44
GSK
GSK
$79.3B
$4.4M 0.79%
130,000
+30,000
+30% +$1.01M
ETNB icon
45
89bio
ETNB
$1.37B
$4.35M 0.79%
556,532
+19,985
+4% +$156K
VIR icon
46
Vir Biotechnology
VIR
$765M
$4.27M 0.77%
581,829
+488,500
+523% +$3.59M
DAWN icon
47
Day One Biopharmaceuticals
DAWN
$766M
$4.24M 0.77%
334,987
-12,640
-4% -$160K
VKTX icon
48
Viking Therapeutics
VKTX
$3.02B
$4.16M 0.75%
103,270
-29,796
-22% -$1.2M
PLRX icon
49
Pliant Therapeutics
PLRX
$105M
$3.92M 0.71%
297,362
– –
AVGO icon
50
Broadcom
AVGO
$1.42T
$3.91M 0.71%
16,880
– –
1
2
3 4 5